̽»¨¾«Ñ¡

Ida Karlsson

Ida Karlsson

Biträdande Lektor | Docent
E-postadress: ida.karlsson@ki.se
µþ±ð²õö°ì²õ²¹»å°ù±ð²õ²õ: Nobels Väg 12a, 17165 Solna
Postadress: C8 Medicinsk epidemiologi och biostatistik, C8 MEB II Hägg Karlsson, 171 77 Stockholm
Del av:

Om mig

Artiklar

  • Article: EBIOMEDICINE. 2025;119:105883
    Ler P; Jylhava J; Hagg S; Finkel D; Aslan AKD; Ploner A; Karlsson IK
  • Article: AGING CELL. 2025;24(8):e70117
    McMmurran CE; Karlsson IK; Mostafaei S; Wang Y; Gerritsen L; Pedersen NL; Haegg S
  • Article: ALZHEIMERS & DEMENTIA. 2025;21(8):e70541
    Saelzler UG; Sundermann EE; Foret JT; Gatz M; Karlsson IK; Pederson NL; Panizzon MS
  • Article: INTERNATIONAL JOURNAL OF OBESITY. 2025;49(7):1327-1333
    Lewitt MS; Karlsson IK; Pedersen NL
  • Article: ALZHEIMERS & DEMENTIA. 2025;21(6):e70176
    Kremen WS; Ericsson M; Gatz M; Karlsson IK; Nygaard M; Pedersen NL; Panizzon MS
  • Article: JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. 2025;16(3):e13824
    Ler P; Mak JKL; Reynolds CA; Ploner A; Pedersen NL; Jylhava J; Aslan AKD; Finkel D; Karlsson IK
  • Article: ENVIRONMENTAL EPIDEMIOLOGY. 2025;9(1):e355
    Jutila O-EI; Mullin D; Vieno M; Tomlinson S; Taylor A; Corley J; Deary IJ; Cox SR; Baranyi G; Pearce J; Luciano M; Karlsson IK; Russ TC
  • Article: DIABETES OBESITY & METABOLISM. 2025;27(1):207-214
    Lindfors EO; De Oliveira TL; Reynolds CA; Zhan Y; Dahl Aslan AK; Jylhava J; Sjolander A; Karlsson IK
  • Journal article: ALZHEIMERS & DEMENTIA. 2024;20(Suppl 1):e088371
    Vella AS; Selwood A; Catts VS; Numbers KT; Lee T; Thalamuthu A; Karlsson IK; Reynolds CA; Franz CE; Kremen WS; Gatz M; Sachdev PS
  • Article: BMJ MENTAL HEALTH. 2024;27(1):e301064
    Zhang A; Zhou L; Meng Y; Ji Q; Ye M; Liu Q; Tan W; Zheng Y; Hu Z; Liu M; Xu X; Karlsson IK; Hagg S; Zhan Y
  • Article: GEROSCIENCE. 2024;46(5):5003-5014
    Shemer DW; Mostafaei S; Tang B; Pedersen NL; Karlsson IK; Fall T; Hagg S
  • Article: AGING CELL. 2024;23(6):e14135
    Mak JKL; Skovgaard AC; Nygaard M; Kananen L; Reynolds CA; Wang Y; Kuja-Halkola R; Karlsson IK; Pedersen NL; Hagg S; Soerensen M; Jylhava J
  • Article: AGING CELL. 2024;23(6):e14132
    De Oliveira TL; Tang B; Bai G; Sjolander A; Jylhava J; Finkel D; Pedersen NL; Hassing LB; Reynolds CA; Karlsson IK; Hagg S
  • Article: GEROSCIENCE. 2024;46(2):2605-2617
    Ler P; Ploner A; Finkel D; Reynolds CA; Zhan Y; Jylhava J; Aslan AKD; Karlsson IK
  • Article: ALZHEIMERS & DEMENTIA. 2024;20(3):1682-1692
    Jang JY; Beam CR; Karlsson IK; Pedersen NL; Gatz M
  • Article: GEROSCIENCE. 2024;46(1):961-968
    Zhang A; Zhang Y; Meng Y; Ji Q; Ye M; Zhou L; Liu M; Yi C; Karlsson IK; Fang F; Haegg S; Zhan Y
  • Article: HELIYON. 2024;10(1):e23415
    Zhu Y; Meng Y; Zhang Y; Karlsson IK; Hagg S; Zhan Y
  • Article: NEUROEPIDEMIOLOGY. 2024;58(4):256-263
    Ye M; Kang X; Karlsson IK; Wang Y; Ji Q; Liu Q; Xu X; Hagg S; Fang F; Wirdefeldt K; Zhan Y
  • Article: JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES. 2024;79(1):gbad153
    Ericsson M; Finch B; Karlsson IK; Gatz M; Reynolds CA; Pedersen NL; Mosing MA; Schafer M
  • Article: EPIGENETICS. 2023;18(1):2158285
    Karlsson IK; Ploner A; Wang Y; Gatz M; Pedersen NL; Haegg S
  • Visa fler

Alla övriga publikationer

  • Preprint: MEDRXIV. 2025
    Herranen P; Palviainen T; Nygaard M; Karlsson IK; Thalamuthu A; Mather KA; Reynolds CA; Panizzon MS; Rantanen T; Finkel D; Gatz M; Pedersen NL; Consortium I; Kaprio J; Sillanpää E
  • Letter: ALZHEIMERS & DEMENTIA. 2025;21(8):e70618
    Kremen WS; Ericsson M; Gatz M; Karlsson IK; Nygaard M; Pedersen NL; Panizzon MS
  • Preprint: MEDRXIV. 2024;MEDRXIV
    Saelzler UG; Sundermann EE; Foret JT; Gatz M; Karlsson IK; Panizzon MS
  • Review: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2024;79(10):glad251
    Mak JKL; Karlsson IK; Tang B; Wang Y; Pedersen NL; Hagg S; Jylhava J; Reynolds CA
  • Review: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(2):422-427
    Ji Q; Lian W; Meng Y; Liu W; Zhuang M; Zheng N; Karlsson IK; Zhan Y
  • Preprint: RESEARCH SQUARE. 2022
    Karlsson I; Ploner A; Wang Y; Gatz M; Pedersen N; Hägg S
  • Preprint: RESEARCH SQUARE. 2022
    Ler P; Li X; Hassing L; Reynolds C; Finkel D; Karlsson I; Aslan AD
  • Preprint: MEDRXIV. 2022
    Karlsson I; Zhan Y; Wang Y; Li X; Jylhava J; Hagg S; Dahl Aslan A; Gatz M; Pedersen N; Reynolds C
  • Preprint: MEDRXIV. 2022
    Ler P; Zhan Y; Finkel D; Dahl Aslan A; Karlsson I
  • Conference publication: INNOVATION IN AGING. 2021;5:245
    Finkel D; Karlsson I; Ericsson M; Russ T; Aslan AD; Pedersen NL
  • Editorial comment: FRONTIERS IN GENETICS. 2021;12:771109
    Karlsson IK; Arpawong TE; Zhan Y; Lehto K
  • Preprint: RESEARCH SQUARE. 2021
    Karlsson I; Ericsson M; Wang Y; Jylhävä J; Hägg S; Aslan AD; Reynolds C; Pedersen N
  • Preprint: MEDRXIV. 2021
    Karlsson I; Zhan Y; Gatz M; Reynolds C; Dahl Aslan A
  • Preprint: RESEARCH SQUARE. 2021
    Karlsson IK; Gatz M; Arpawong TE; Aslan AKD; Reynolds CA
  • Preprint: MEDRXIV. 2020
    Wightman D; Jansen I; Savage J; Shadrin A; Bahrami S; Rongve A; Børte S; Winsvold B; Drange OK; Martinsen A; Skogholt AH; Willer C; Bråthen G; Bosnes I; Nielsen JB; Fritsche L; Thomas L; Pedersen L; Gabrielsen M; Johnsen MB; Meisingset TW; Zhou W; Proitsi P; Hodges A; Dobson R; Velayudhan L; 23andMe Research Team; Sealock J; Davis L; Pedersen N; Reynolds C; Karlsson I; Magnusson S; Stefansson H; Thordardottir S; Jonsson P; Snaedal J; Zettergren A; Skoog I; Kern S; Waern M; Zetterberg H; Blennow K; Stordal E; Hveem K; Zwart J-A; Athanasiu L; Saltvedt I; Sando S; Ulstein I; Djurovic S; Fladby T; Aarsland D; Selbæk G; Ripke S; Stefansson K; Andreassen O; Posthuma D
  • Letter: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2020;28(4):499-500
    Kodesh A; Sandin S; Reichenberg A; Rotstein A; Pedersen NL; Ericsson M; Karlsson IK; Davidson M; Levine SZ
  • Conference publication: BEHAVIOR GENETICS. 2019;49(6):512
    Lehto K; Karlsson I; Gatz M; Pedersen NL
  • Conference publication: BEHAVIOR GENETICS. 2019;49(6):503
    Karlsson I; Ericsson M; Wang Y; Jylhava J; Hagg S; Aslan AD; Reynolds C; Pedersen NL
  • Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S181-S182
    Lehto K; Karlsson I; Gatz M; Pedersen NL
  • Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S180-S181
    Karlsson I; Lehto K; Reynolds CA; Aslan AD
  • Visa fler

Forskningsbidrag

  • Obesitas och specifika subtyper: FrÃ¥n body mass index mot precisionsmedicin
    ̽»¨¾«Ñ¡s Forskningsbidrag
    1 November 2024 - 31 October 2026
  • National Institute on Aging
    1 August 2024 - 30 April 2030
  • National Institute on Aging
    15 May 2024 - 28 February 2029
  • Overweight as a heterogenous phenotype - Leveraging differences to understand effects on age-related diseases
    The Strategic Research Program in Epidemiology at ̽»¨¾«Ñ¡
    1 November 2023 - 31 December 2023
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2023 - 31 December 2025
    Research problem and specific questions The purpose of this project is to leverage the heterogeneity of overweight to understand how overweight increases the risk of cardiovascular disease, type 2 diabetes, and dementia. We will study adiposity in general and specific adiposity-related traits:Metabolically unhealthy vs healthy adiposityEnvironmentally vs genetically driven adiposityAdiposity measured in midlife vs late-lifeThus, we can study differences in how the adiposity-related traits associate with the age-related diseases, and if these differences are explained by mediating factors or by an acceleration of aging. We will study:Overweight in general, to highlight genes and biological pathways shared between adiposity and the age-related diseases, and seek to identify factors driving the associations.How metabolic biomarkers (e.g. cholesterol levels, inflammatory markers) and other potential mediators (e.g. depressive symptoms) differ among the adiposity-related traits, and if these factors influence the associations with the age-related diseases.If cellular or multisystem aging (telomere length, epigenetic clocks, and frailty) differ among the adiposity-related traits, and influence the association with the age-related diseases.Data and methodAim 1 uses genetic designs and public data. Aim 2-3 applies advanced epidemiological designs to large longitudinal data from the Health and Retirement Study (USA
    n=37,494) and twin cohorts in the IGEMS consortium (Australia, Denmark, Sweden, and USA
    n=89-136).Plan for project realizationThe data are already available, and the realization and costs concern analyses to answer the research questions. The project is led by an interdisciplinary team of researchers in Sweden, China, and the USA. We will recruit a PhD student, who will conduct four studies within the project, and budget for partial financing of a present PhD student, whose work falls within the proposed project.RelevancePreliminary analyses indicate important differences among the adiposity-related traits, and by examining these differences the project will advance our understanding of the heterogeneity of overweight, and of what drives the negative health effects of adiposity in general. It thereby has the potential to identify preventive strategies reducing the risk of several of our most common causes of morbidity and mortality, and promote a healthier aging.
  • Overweight as a heterogeneous phenotype: Leveraging differences among adiposity-related traits to understand effects on age-related disease
    Foundation for Geriatric Diseases at ̽»¨¾«Ñ¡
    1 October 2022 - 30 September 2025
  • Overweight as a heterogeneous phenotype - Leveraging differences to understand effects on age-related diseases
    ̽»¨¾«Ñ¡â€™s Research Foundation
    1 October 2022 - 30 September 2024
  • Overweight as a heterogeneous phenotype: Leveraging differences among adiposity-related traits to understand effects on age-related disease
    Loo and Hans Osterman Foundation for Medical Research
    1 July 2022 - 30 June 2025
  • Overweight as a heterogeneous phenotype: Leveraging differences in adiposity-related traits to understand effects on age-related disease
    The Strategic Research Program in Epidemiology at ̽»¨¾«Ñ¡
    1 November 2021 - 31 December 2023
  • Council for International Exchange of Scholars
    1 August 2019 - 29 February 2020
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2019 - 31 December 2020

´¡²Ô²õ³Ùä±ô±ô²Ô¾±²Ô²µ²¹°ù

  • Biträdande Lektor, Medicinsk epidemiologi och biostatistik, ̽»¨¾«Ñ¡, 2022-2028
  • Postdoktor, Medicinsk epidemiologi och biostatistik, ̽»¨¾«Ñ¡, 2021-2022
  • Postdoctoral Researcher, Hälsohögskolan, Institutet för Gerontologi, Jönköping University, 2017-2020
  • Doktorand, Medicinsk epidemiologi och biostatistik, ̽»¨¾«Ñ¡, 2012-2017
  • FOU-Praktikant, Medicinsk epidemiologi och biostatistik, ̽»¨¾«Ñ¡, 2011-2012

Examina och utbildning

  • Docent, Epidemiologi, ̽»¨¾«Ñ¡, 2024
  • Medicine Doktorsexamen, Institutionen för medicinsk epidemiologi och biostatistik, ̽»¨¾«Ñ¡, 2017
  • Medicine Magisterexamen, ̽»¨¾«Ñ¡, 2010

Uppdrag

Uppdrag i kommitté

  • Medlem, Junior Faculty Steering Group, ̽»¨¾«Ñ¡, 2024-
  • Medlem, MEB Work Environment Group, Department of Medical Epidemiology and Biostatistics, ̽»¨¾«Ñ¡, 2021-

Gästforskning och resestipendier

  • Fulbright Scholar, University of California, Riverside, , 2019-2020
  • Eurolife Postdoc Mobility and Knowledge Exchange, University of Edinburgh

Redaktör för vetenskaplig tidskrift

  • Behavior Genetics, Biträdande redaktör, , 2025

Nyheter från KI

Kalenderhändelser från KI